Literature DB >> 21063728

Clinical practice: proteinuria.

Gema Ariceta1.   

Abstract

Proteinuria detection in children is a challenge. Five percent to 15% and 0.4-1% of school children present either transient (benign) or persistent increased amount of protein in urine, respectively. Persistent proteinuria constitutes not only a sign of overt kidney disease but may also be the first indicator of silent renal damage. Proteinuria is a marker for hyperfiltration in individuals with reduced nephron mass and one of the most important independent risk factor for renal disease progression as well. It constitutes the single most important risk factor for future loss of kidney function, preceding glomerular filtration rate reduction. Further, proteinuria itself is diagnostic of cardiovascular disease with prognostic value and target organ involvement in high-risk populations such as diabetic, obese, hypertensive children, or those with known reduced renal mass or previous renal injury. Current strategies to prevent CKD progression, a concept known as renoprotection, are focused on reducing urinary protein excretion among other factors. Reversibility of organ damage in early stages is possible; therefore, pediatricians should screen children for proteinuria or microalbuminuria, mainly in high-risk groups.

Entities:  

Mesh:

Year:  2010        PMID: 21063728     DOI: 10.1007/s00431-010-1334-0

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  35 in total

1.  Tubular proteinuria defined by a study of Dent's (CLCN5 mutation) and other tubular diseases.

Authors:  A G Norden; S J Scheinman; M M Deschodt-Lanckman; M Lapsley; J L Nortier; R V Thakker; R J Unwin; O Wrong
Journal:  Kidney Int       Date:  2000-01       Impact factor: 10.612

2.  Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE).

Authors:  R J Hogg; R J Portman; D Milliner; K V Lemley; A Eddy; J Ingelfinger
Journal:  Pediatrics       Date:  2000-06       Impact factor: 7.124

Review 3.  Properties of the glomerular barrier and mechanisms of proteinuria.

Authors:  Börje Haraldsson; Jenny Nyström; William M Deen
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

4.  Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Northern Italian Cooperative Study Group.

Authors:  F Locatelli; D Marcelli; M Comelli; D Alberti; G Graziani; G Buccianti; B Redaelli; A Giangrande
Journal:  Nephrol Dial Transplant       Date:  1996-03       Impact factor: 5.992

Review 5.  Glomerulonephritis.

Authors:  S J Chadban; R C Atkins
Journal:  Lancet       Date:  2005 May 21-27       Impact factor: 79.321

6.  X-linked recessive nephrolithiasis with renal failure.

Authors:  P A Frymoyer; S J Scheinman; P B Dunham; D B Jones; P Hueber; E T Schroeder
Journal:  N Engl J Med       Date:  1991-09-05       Impact factor: 91.245

7.  Strict blood-pressure control and progression of renal failure in children.

Authors:  Elke Wühl; Antonella Trivelli; Stefano Picca; Mieczyslaw Litwin; Amira Peco-Antic; Aleksandra Zurowska; Sara Testa; Augustina Jankauskiene; Sevinc Emre; Alberto Caldas-Afonso; Ali Anarat; Patrick Niaudet; Sevgi Mir; Aysin Bakkaloglu; Barbara Enke; Giovanni Montini; Ann-Margret Wingen; Peter Sallay; Nikola Jeck; Ulla Berg; Salim Caliskan; Simone Wygoda; Katharina Hohbach-Hohenfellner; Jiri Dusek; Tomasz Urasinski; Klaus Arbeiter; Thomas Neuhaus; Jutta Gellermann; Dorota Drozdz; Michel Fischbach; Kristina Möller; Marianne Wigger; Licia Peruzzi; Otto Mehls; Franz Schaefer
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

8.  Renal manifestations of Dent disease and Lowe syndrome.

Authors:  Hee Yeon Cho; Bum Hee Lee; Hyun Jin Choi; Il Soo Ha; Yong Choi; Hae Il Cheong
Journal:  Pediatr Nephrol       Date:  2007-11-24       Impact factor: 3.714

Review 9.  Nephrotic syndrome in childhood.

Authors:  Allison A Eddy; Jordan M Symons
Journal:  Lancet       Date:  2003-08-23       Impact factor: 79.321

10.  Renoprotection by ACE inhibitors after severe hemolytic uremic syndrome.

Authors:  Maria Van Dyck; Willem Proesmans
Journal:  Pediatr Nephrol       Date:  2004-04-03       Impact factor: 3.714

View more
  9 in total

Review 1.  Acute hemorrhagic edema of young children: a concise narrative review.

Authors:  Elisabetta Fiore; Mattia Rizzi; Giacomo D Simonetti; Luca Garzoni; Mario G Bianchetti; Alberto Bettinelli
Journal:  Eur J Pediatr       Date:  2011-06-15       Impact factor: 3.183

2.  Urinary stone risk factors in the descendants of patients with kidney stone disease.

Authors:  Thasinas Dissayabutra; Nuttiya Kalpongkul; Jakkhaphan Rattanaphan; Chanchai Boonla; Monpicha Srisa-Art; Wattanachai Ungjaroenwathana; Piyaratana Tosukhowong
Journal:  Pediatr Nephrol       Date:  2018-03-28       Impact factor: 3.714

3.  How to define and assess the clinically significant causes of hematuria in childhood.

Authors:  Orsolya Horváth; Attila J Szabó; George S Reusz
Journal:  Pediatr Nephrol       Date:  2022-10-19       Impact factor: 3.651

4.  Relation of resistın wıth obesity and some cardiovascular risk factors in hypertensive women.

Authors:  Gül Gürsoy; Sena Ulu; Yaşar Acar; Berrin Demirbaş; Süleyman Alkan; Birsen Erol; Işıl Ozaşık
Journal:  J Res Med Sci       Date:  2012-05       Impact factor: 1.852

5.  Simplified Algorithm for Evaluation of Proteinuria in Clinical Practice: How should A Clinician Approach?

Authors:  Mojgan Mazaheri; Farahnak Assadi
Journal:  Int J Prev Med       Date:  2019-03-05

6.  Persistent Abnormalities of Fatty Acids Profile in Children With Idiopathic Nephrotic Syndrome in Stable Remission.

Authors:  Stefano Turolo; Alberto C Edefonti; William Morello; Marie-Louise Syren; Valentina De Cosmi; Luciana Ghio; Chiara Tamburello; Erika A Demarco; Alfredo Berrettini; Gianantonio Manzoni; Carlo Agostoni; Giovanni Montini
Journal:  Front Pediatr       Date:  2021-01-27       Impact factor: 3.418

7.  Enhanced MCP-1 Release in Early Autosomal Dominant Polycystic Kidney Disease.

Authors:  Peter Janssens; Jean-Paul Decuypere; Stéphanie De Rechter; Luc Breysem; Dorien Van Giel; Jaak Billen; An Hindryckx; Luc De Catte; Marcella Baldewijns; Kathleen B M Claes; Karl M Wissing; Koen Devriendt; Bert Bammens; Isabelle Meyts; Vicente E Torres; Rudi Vennekens; Djalila Mekahli
Journal:  Kidney Int Rep       Date:  2021-04-06

8.  Highlights for the management of a child with proteinuria and hematuria.

Authors:  Jyothsna Gattineni
Journal:  Int J Pediatr       Date:  2012-07-12

9.  Longitudinal Study of the Role of Epidermal Growth Factor on the Fractional Excretion of Magnesium in Children: Effect of Calcineurin Inhibitors.

Authors:  Kristien J Ledeganck; Charlotte Anné; Amandine De Monie; Sarang Meybosch; Gert A Verpooten; Marleen Vinckx; Koen Van Hoeck; Annelies Van Eyck; Benedicte Y De Winter; Dominique Trouet
Journal:  Nutrients       Date:  2018-05-27       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.